Every year, I watch benefits teams chase the latest shiny object: a new point solution, a rebate tweak, a wellness challenge that promises to get people walking more. And every year, the same plan document sits on a shared drive somewhere, barely touched except when compliance asks for an update. That's a mistake. A self-funded plan's SPD isn't just legal paperwork. It's the most potent cost-containment tool nobody's using, and once you see what it can do, you stop worrying about whether your carrier got you an extra two points on a PPO discount.
The Quiet Power of ERISA Preemption
Let's get one thing straight: fully insured employers are stuck. Whatever your state mandates (IVF, bariatric surgery, certain autism therapies), you're paying for it. Self-funded plans don't have that problem. Under ERISA Section 514, those state mandates simply don't apply. You're free to decide what your plan covers, based on evidence and value rather than a lobbyist's wish list. Use that freedom to remove services that don't hold up under scrutiny while keeping the benefits people value. The freedom has limits. Section 514 wipes out state insurance mandates only. The Affordable Care Act's preventive-services and out-of-pocket rules, the Mental Health Parity and Addiction Equity Act, and the rest of ERISA and the Internal Revenue Code still bind a self-funded plan just as they do an insured one.
Redefine "Medical Necessity" So It Actually Means Something
Most plan documents borrow a mushy definition: "consistent with generally accepted standards of practice," "not for patient convenience." Sound familiar? That language is porous enough to drive a truck through. A cost-containment plan needs teeth.
Write your definition to require treatments that have proven efficacy through randomized controlled trials or systematic reviews in peer-reviewed literature. Then go further: explicitly exclude services flagged as low-value by the USPSTF's "D" recommendations and the Choosing Wisely campaign. Add one more line: any covered service must be delivered in the lowest-cost appropriate setting. That's your site-of-care steerage baked directly into the plan, not dependent on network contracting.
When a claim is denied based on your plan's own definition, it's far harder to overturn on appeal than a denial rooted in some TPA's internal guideline. You own the language. The administrator just applies it. That's a legal and financial moat, plain and simple.
Stop Hiding Your Rules in Vendor Contracts
Utilization management doesn't belong in a PBM's black box or a stop-loss carrier's proprietary protocol. Put it in the SPD where it belongs:
- Step therapy that sticks. Before a specialty drug is covered, the member must have failed a generic or preferred brand. Physician override? Only through a formal appeal with independent external review. No shortcuts.
- Imaging and surgery guardrails. Require prior authorization for every MRI, CT scan, and elective joint replacement. Stipulate that imaging must be done at designated high-value imaging centers, and coverage is contingent on using a shared decision-making tool.
- Infusion site redirection. Declare that certain infusions are covered only in a physician's office or community-based setting, not a hospital outpatient department. If the member gets the infusion at a hospital, the plan doesn't pay, period. That's an exclusion, not a network steerage difference.
These are thoughtful rules that guide people to the right care at the right price, with the full force of the plan document behind them.
Carve Out High-Cost Providers Without Building a Network
You don't need a narrow network to avoid outlier pricing. Use your SPD to create a "designated provider" panel for high-cost elective procedures. List specific Centers of Excellence (COEs) for hip and knee replacements, spinal surgeries, bariatric procedures. Then state clearly: services from anyone else are simply not covered. None of the usual out-of-network reimbursement mess applies: these are plan exclusions, not out-of-network payment disputes, and the No Surprises Act's surprise-billing rules don't turn a service the plan excludes into a covered one.
With the price transparency data plans are now required to publish, you can name those COEs based on actual cost and quality metrics. Update them annually in the plan document. Pair that with a TPA that manages bundled payments directly, and you've built a cost firewall without a single network contract negotiation.
Pharmacy Fine Print You're Probably Overlooking
The SPD can reshape drug spend just as aggressively:
- Mandatory generic substitution with no loopholes unless the physician submits lab evidence of intolerance. Not a note. Lab evidence.
- Copay accumulator programs. State unambiguously that manufacturer copay assistance doesn't count toward the member's deductible or out-of-pocket max. The legal ground has shifted here. A 2023 federal district court vacated the regulation that authorized accumulators and held that plans must follow the older 2020 rule, which counts assistance toward cost-sharing for brand drugs with no generic available. HHS has not issued a replacement rule or enforced that requirement. ERISA preemption still shields self-funded plans from state accumulator bans, but write this language only after benefits counsel reviews it.
- White-bagging and brown-bagging. Physician-administered specialty drugs must come through the plan's designated specialty pharmacy and be shipped to the provider. That kills buy-and-bill markups. Spell it out in the SPD so neither the provider nor the member is surprised.
Enrollment Design: The Missing Piece
You can write the perfect plan document, and it won't matter if your employees cluster in the expensive PPO with the broad network. The fix? Treat enrollment itself as a cost-containment channel.
- Smart defaults. Anyone who doesn't actively choose gets enrolled in the highest-value plan, typically an HDHP with an HSA, rather than defaulting to last year's selection.
- Personalized cost projections. Give employees a simple tool that shows their own forecasted total spending (premiums plus expected out-of-pocket) under each plan option, using their actual claims history. When people see they'll pay thousands more for the same care in the buy-up plan, many shift. Loss aversion does the work for you.
- Two well-designed choices. Stop offering three or four plans that fragment the risk pool. Offer two: a solid HDHP and a value-network plan, both loaded with high-value features like free preventive care, low-cost chronic meds, and telehealth first. Every option is cost-effective for the employer, and employees still have a meaningful choice.
Aggressive Exclusions Invite Class-Action Scrutiny
The same plan language that protects you also gets read in a deposition. Health-plan benefit litigation is surging: about 70 proposed ERISA class actions landed in the first quarter of 2026, up from fewer than 40 in the same period a year earlier, and roughly one in five ERISA lawsuits in 2025 involved health plans. Settlements over medical-necessity denials keep landing. Anthem reached a $3.6 million settlement in August 2026 over proton-beam therapy for prostate cancer, and it resolved residential-treatment denial claims in late 2025.
This is an argument for evidence, not against rewriting the SPD. The medical-necessity definition you write has to hold up in front of a judge, which means the clinical literature you cite has to exist and say what you think it says. Keep the citation behind every exclusion, document the review that produced each rule, and apply the language the same way every time. A plan that can show its rules came from peer-reviewed evidence, and were applied evenly, wins the cases that a plan with a clever but unsupported exclusion loses.
Don't Skip the Compliance Guardrails
Wielding the SPD this aggressively demands some discipline:
- Write for the average participant. Every exclusion, limit, and prior authorization requirement needs to be understandable. The DOL is paying closer attention to denials that depend on dense, buried language.
- Stay clear of discrimination. You can't design benefits or enrollment rules that disadvantage people based on health factors. Excluding specific services based on solid evidence, not broad disease categories, keeps you on solid ground.
- Keep your appeals process tight. Provide timely internal appeals and access to independent external review. A plan that systematically denies beneficial care without rock-solid evidence is asking for a class-action suit.
Most employers treat the SPD like a static piece of compliance. They're leaving millions on the table. The ones who treat it like a strategy document, rewriting definitions, embedding utilization rules, carving out waste, and pairing it with behavioral enrollment design, are rewriting the economics of the plan from the inside out, not merely trimming costs. And it's a lot more interesting than arguing over PPO discounts.